In his resignation email, Dr. Brian Druker emphasized that the university had lost sight of its core mission, stating, "I can no longer pursue my goals to advance cancer research and improve care here at OHSU." His departure highlights concerns about the institution's direction and commitment to critical health initiatives.
Druker's resignation as CEO of the Knight Cancer Institute comes amid frustrations with OHSU's vision. He pointedly mentioned, "The commitment to breakthrough cancer research and quality patient care is paramount, yet I feel these objectives have been overshadowed at the institution." This raises questions about leadership priorities.
Collection
[
|
...
]